- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/775 - Apolipopeptides
Patent holdings for IPC class C07K 14/775
Total number of patents in this class: 637
10-year publication summary
|
25
|
35
|
41
|
36
|
35
|
24
|
32
|
38
|
46
|
8
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 20473 |
26 |
| CSL Limited | 251 |
15 |
| ABIONYX Pharma SA | 49 |
15 |
| Cornell University | 3385 |
12 |
| Lawrence Livermore National Security, LLC | 1956 |
11 |
| F. Hoffmann-La Roche AG | 7874 |
9 |
| Cerenis Therapeutics Holding SA | 25 |
9 |
| Children's Medical Center Corporation | 1925 |
9 |
| University of Cincinnati | 900 |
8 |
| Theripion, Inc. | 18 |
8 |
| The General Hospital Corporation | 4810 |
7 |
| Toray Industries, Inc. | 7023 |
7 |
| Cleveland HeartLab, Inc. | 23 |
7 |
| Indiana University Research and Technology Corporation | 792 |
7 |
| The Jackson Laboratory | 368 |
7 |
| National Cancer Center | 438 |
7 |
| Bio-trip B.V. | 14 |
7 |
| Centre National de La Recherche Scientifique | 10841 |
6 |
| Duke University | 3169 |
6 |
| Alnylam Pharmaceuticals, Inc. | 1165 |
6 |
| Other owners | 448 |